1. Home
  2. PHAT vs EVER Comparison

PHAT vs EVER Comparison

Compare PHAT & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$11.56

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo EverQuote Inc.

EVER

EverQuote Inc.

HOLD

Current Price

$15.92

Market Cap

929.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAT
EVER
Founded
2018
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
929.5M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
PHAT
EVER
Price
$11.56
$15.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$19.50
$27.00
AVG Volume (30 Days)
898.5K
1.3M
Earning Date
05-28-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
42.72
198.86
EPS
N/A
2.63
Revenue
$175,110,000.00
$163,349,000.00
Revenue This Year
$83.18
$13.30
Revenue Next Year
$61.43
$12.79
P/E Ratio
N/A
$5.97
Revenue Growth
216.93
N/A
52 Week Low
$2.21
$13.93
52 Week High
$18.31
$30.03

Technical Indicators

Market Signals
Indicator
PHAT
EVER
Relative Strength Index (RSI) 39.53 35.65
Support Level $10.65 $13.93
Resistance Level $12.77 $26.89
Average True Range (ATR) 0.87 0.97
MACD 0.09 0.39
Stochastic Oscillator 14.01 60.09

Price Performance

Historical Comparison
PHAT
EVER

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

Share on Social Networks: